Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Refractory <i>Candidozyma</i> (<i>Candida</i>) <i>auris</i>-associated central nervous system infection in a postoperative neurosurgical patient.

ASM case reports·2026
Same author

High-throughput multiplex detection of respiratory pathogens: multicenter evaluation of the NxTAG Respiratory Pathogen Panel v2 assay.

Journal of clinical microbiology·2026
Same author

Diagnostic Approaches for Measles Virus: Methods, Advances, and Ongoing Challenges.

Pathogens (Basel, Switzerland)·2025
Same author

Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Nature·2025
Same author

Evaluation of a Novel Rapid Phenotypic Antimicrobial Susceptibility Testing System.

Antibiotics (Basel, Switzerland)·2025
Same author

Photo Quiz: Unexpected yeast in a premature infant-pathogen or passenger.

Journal of clinical microbiology·2025

相关实验视频

Updated: Jul 15, 2025

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
07:08

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System

Published on: April 6, 2021

5.1K

一个集成的研究和临床BSL-2平台,用于活体SARS-CoV-2中和试验.

Jing Zou1, Chaitanya Kurhade2, Hope C Chang2

  • 1Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Viruses
|September 28, 2023
PubMed
概括

我们开发了一种使用减弱病毒的安全和快速活体SARS-CoV-2中和试验. 这个平台在24小时内有效地检测出针对SARS-CoV-2关注变种 (VOCs) 的中和抗体.

关键词:
在 COVID-19 疫情中,这就是SARS-CoV-2病毒.高吞吐量,具有高吞吐量.活体减弱 活体减弱中和测试试验 中和测试试验血清学诊断 血清学诊断 血清学诊断有关关注的变种.

更多相关视频

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.7K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.2K

相关实验视频

Last Updated: Jul 15, 2025

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
07:08

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System

Published on: April 6, 2021

5.1K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.7K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.2K

科学领域:

  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学
  • 公共卫生 公共卫生

背景情况:

  • 对抗SARS-CoV-2及其令人担忧的变体 (VOCs) 的中和抗体的监测需要可靠和高效的血清学测试.
  • 现有的测定可能在安全性,速度或变种检测范围方面存在局限性.

研究的目的:

  • 为活体SARS-CoV-2中和试验提供一个综合的研究临床平台.
  • 为了能够安全地处理和快速评估针对SARS-CoV-2和VOCs的中和标位.

主要方法:

  • 开发一种高度减弱的SARS-CoV-2菌株 (Δ3678_WA1-spike),用于生物安全级别2 (BSL-2) 实验室的安全使用.
  • 基因稳定的记者病毒 (mGFP Δ3678_WA1-spike,mGFP Δ3678_BA.5-spike,mGFP Δ3678_XBB.1.5-spike) 的构建,其中包含一个改性绿色光蛋白 (mGFP).
  • 优化光减少中和试验和机器人辅助工作流程,以快速 (24小时) 且准确地评估中和标位.

主要成果:

  • 报告病毒表现出强大的光信号和中和标位,与传统的斑块减少试验高度相关.
  • 机器人辅助的工作流显示出灵敏度,特异性,可重复性和准确性.
  • 该试验在样本接收后24小时内成功评估了针对SARS-CoV-2变种的中和度.

结论:

  • 开发的平台为对BSL-2的SARS-CoV-2和VOC进行大规模临床样本测试提供了有价值的工具.
  • 这种创新方法通过快速监测抗体反应来支持流行病准备和应对策略.
  • 该试验的安全性,效率和准确性使其适用于临床和研究应用.